04:55 PM EDT, 09/06/2024 (MT Newswires) -- FibroGen ( FGEN ) said Friday it issued termination notices to Chief Financial Officer Juan Graham and Chief Medical Officer Deyaa Adib on Aug. 30 as part of the company's cost-cutting plan in the US.

Both executives will remain with the company through a transition period, with Graham leaving on Dec. 15 while Adib will depart on Nov. 1, the company said in a filing with the US Securities and Exchange Commission.

FibroGen ( FGEN ) said the terminations are not due to any disagreement with the company.